Product Introduction

ACCUiN α/β Thalassemia Screening Kit is a qualitative detection designed using Polymerase Chain Reaction (PCR) technology, utilizing primers to specifically amplify specific regions of human HBA1, HBA2, and HBB genes, followed by capillary electrophoresis analyzer and Sanger sequencing technology to analyze variant status. ACCUiN α/β Thalassemia Screening Kit can be used to detect whether test samples have single nucleotide variants (SNVs), multi-nucleotide variants (MNVs), insertions, deletions, or insertion/deletion (INDELs) variants in HBA1 (NM_000558), HBA2 (NM_000517), and HBB (NM_000518). ACCUiN α/β Thalassemia Screening Kit has passed quality validation and functional verification to ensure performance stability and reproducibility. ACCUiN α/β Thalassemia Screening Kit can provide at least 48 detection reactions.